Boothwyn Pharmacy Recalls

4 recalls found for Boothwyn Pharmacy. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DRUG

Boothwyn Pharmacy Semaglutide Injection Recall for Subpotent Drug (High-Risk)

Boothwyn Pharmacy LLC issued a nationwide recall of 186 vials of Semaglutide 2.5 mg/mL injection, 0.8 mL, on July 9, 2025. The FDA enforcement report classifies the recall as Class II with a high hazard level. Consumers and healthcare providers should stop using the product immediately and follow guidance from Boothwyn Pharmacy or a healthcare provider.

Boothwyn Pharmacy
Subpotent Drug
Read more
Health & Personal Care
HIGH
FDA DRUG

Boothwyn Pharmacy Semaglutide Injection Recall for Subpotent Drug (4 mL, 2.5 mg/mL)

Boothwyn Pharmacy recalls 648 vials of semaglutide 2.5 mg/mL injection nationwide after detecting subpotent potency. The recall involves products distributed across the U.S. and is classified as Class II with a high hazard level. Stop using the product and contact Boothwyn Pharmacy or a healthcare provider for guidance.

Boothwyn Pharmacy
Subpotent Drug
Read more

Brand Statistics

Total Recalls
4
Pages
1

Related Brands

GLYCOPYRROLATEZimmer SurgicalEthicon Endo-SurgeryStuffed FoodsStryker Sustainability SolutionsBlue WaveAisstxoerMeridian Bioscience